Efficacy and safety of intraperitoneally administered resveratrol against rat orthotopic ovarian cancers

BACKGROUND: Resveratrol (Res) inhibits ovarian cancer (OC) cell growth but its in vivo anti-OC effects are unclear due to the low bioavailability of systemically administered Res. Intraperitoneal administration may overcome this therapeutic dilemma because it makes Res directly affect the abdominal...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Manag Res
Main Authors: Zhong, Li-Xia, Wu, Mo-Li, Li, Hong, Liu, Jia, Lin, Li-Zhu
Format: Artigo
Language:Inglês
Published: Dove 2019
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6620774/
https://ncbi.nlm.nih.gov/pubmed/31456648
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S206301
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items